This article was automatically translated from the original Turkish version.
Quality-Adjusted Life Year (English: Quality-Adjusted Life Year, abbreviated as QALY) is a unit used to measure the outcome of a health intervention or health condition. This metric combines changes in both the duration of life (quantity) and the quality of that life (quality) into a single index. QALY was developed particularly in the field of health economics to assist decision-making processes regarding how limited resources should be allocated among different health programs and technologies.
QALY is calculated by multiplying the length of time a person spends in a specific health state by the quality-of-life weight assigned to that state. In this calculation, quality of life is typically rated on a scale from 0 to 1. On this scale, a value of 1 represents perfect health, while a value of 0 represents death. In some cases, negative values may also be used for health states considered worse than death.
One QALY is equivalent to one year lived in perfect health. For example, a person who lives for 10 years in a health state rated at a quality-of-life index of 0.8 has a total QALY value of 8 (10 years × 0.8). The benefit provided by a health intervention is expressed as a “QALY gain.” This gain reflects the difference in both quality of life and life expectancy before and after the intervention. An example calculation can be performed as follows:【1】 :
This calculation method aims to provide a common basis for comparing different diseases, patient groups, and treatment regimens.
The emergence of the QALY concept is closely linked to changes in the understanding of health. The World Health Organization’s (WHO) 1946 definition of health not merely as the absence of disease or infirmity but as “a state of complete well-being in physical, mental, and social aspects【2】 ” elevated the importance of quality of life in health assessments. As life expectancy increased and chronic diseases became more prevalent, the goals of medical interventions expanded to include not only extending life but also improving its quality. In this context, a standardized unit capable of measuring the efficiency of different health outcomes became necessary.
The theoretical foundation of the QALY approach rests on neoclassical welfare economics. According to this theory, under a fixed health budget, the objective is to maximize the total health benefit to society, measured in QALYs. The validity of this model depends on a set of assumptions.【3】 :
In practice, it is generally impossible to satisfy all these assumptions, which leads to practical limitations and criticisms of the QALY approach.
QALY is most commonly used in health technology assessments and resource allocation decisions.
QALY forms the basis of cost-utility analyses. In these analyses, the Incremental Cost-Effectiveness Ratio (ICER) is calculated to determine how cost-effective one health intervention is compared to another (or to no intervention). ICER is calculated by dividing the difference in cost between two interventions by the difference in QALY gain between them.【4】 :
<span class="katex"><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:0.6833em;"></span><span class="mord text"><span class="mord">ICER</span></span><span class="mspace" style="margin-right:0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right:0.2778em;"></span></span><span class="base"><span class="strut" style="height:1.3355em;vertical-align:-0.4033em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.9322em;"><span style="top:-2.655em;"><span class="pstrut" style="height:3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Etkililik A</span></span><span class="mbin mtight">−</span><span class="mord text mtight"><span class="mord mtight">Etkililik B</span></span></span></span></span><span style="top:-3.23em;"><span class="pstrut" style="height:3em;"></span><span class="frac-line" style="border-bottom-width:0.04em;"></span></span><span style="top:-3.4461em;"><span class="pstrut" style="height:3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Maliyet A</span></span><span class="mbin mtight">−</span><span class="mord text mtight"><span class="mord mtight">Maliyet B</span></span></span></span></span></span><span class="vlist-s"></span></span><span class="vlist-r"><span class="vlist" style="height:0.4033em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span><span class="mspace" style="margin-right:0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right:0.2778em;"></span></span><span class="base"><span class="strut" style="height:0.8889em;vertical-align:-0.1944em;"></span><span class="mord text"><span class="mord">QALY ba</span><span class="mord accent"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height:0.4306em;"><span style="top:-3em;"><span class="pstrut" style="height:3em;"></span><span class="mord">s</span></span><span style="top:-3em;"><span class="pstrut" style="height:3em;"></span><span class="accent-body" style="left:-0.2222em;"><span class="mord">¸</span></span></span></span><span class="vlist-s"></span></span><span class="vlist-r"><span class="vlist" style="height:0.1701em;"><span></span></span></span></span></span><span class="mord latin_fallback">ı</span><span class="mord"> maliyet</span></span></span></span></span>
The resulting ICER value is compared with a pre-determined "payment threshold." If the cost per QALY of an intervention is below this threshold, the intervention is considered "cost-effective." Institutions such as the National Institute for Health and Care Excellence (NICE) in the United Kingdom use such threshold values as a reference in reimbursement decisions. The World Health Organization has suggested that one to three times a country's gross domestic product per capita may serve as a potential threshold range. However, the use of a fixed threshold value and how it should be determined remain subjects of significant debate, particularly across different health systems such as fixed-budget Beveridge-type systems versus unfunded Bismarck-type systems.
Quality of life weights (utility values) required for QALY calculations are obtained through various methods. These methods are divided into two categories: "direct" and "indirect."
These techniques directly measure individuals' preferences.
Multi-dimensional questionnaires are used to describe individuals' health states. The health profiles derived from these questionnaires are converted into a single QALY score using previously established sets of utility values (algorithms) obtained from general population samples. Commonly used indirect scales include EQ-5D,SF-6DandHealth Utility Index (HUI)【5】 bulunur. EQ-5D evaluates five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
Although presented as a tool for the rational allocation of health resources, QALY has faced numerous theoretical and ethical criticisms. Criticisms generally focus on its utilitarian foundations, concerns about equity and discrimination, and the narrow scope of value judgments.
QALY maximization is based on a utilitarian approach that seeks to achieve the greatest good for the greatest number. Ethicists argue that this approach may overlook other moral values such as individual rights and justice.
Criticisms of QALY have led to the development of alternative or complementary models. Some of these include:
[1]
Şelale Şahin, Selime Toprak ve Erdinç Ünal, "QALY; Kaliteye Ayarlı Yaşam Yılları," Medicine Science 1, no. 3 (2012): 235, https://www.researchgate.net/publication/267706671_QALY_Kaliteye_Ayarli_Yasam_Yillari_QALY_Quality_Adjusted_Life_Year.
[2]
Şelale Şahin, Selime Toprak ve Erdinç Ünal, "QALY; Kaliteye Ayarlı Yaşam Yılları," Medicine Science 1, no. 3 (2012): 233, https://www.researchgate.net/publication/267706671_QALY_Kaliteye_Ayarli_Yasam_Yillari_QALY_Quality_Adjusted_Life_Year.
[3]
Irina Cleemput, Mattias Neyt, Nancy Thiry, Chris De Laet ve Mark Leys, “Using Threshold Values for Cost per Quality-Adjusted Life-Year Gained in Healthcare Decisions,” International Journal of Technology Assessment in Health Care 27, no. 1 (2011): 72, https://pmc.ncbi.nlm.nih.gov/articles/PMC5060157/pdf/HEX-5-210.pdf#page=2.
[4]
Şelale Şahin, Selime Toprak ve Erdinç Ünal, "QALY; Kaliteye Ayarlı Yaşam Yılları," Medicine Science 1, no. 3 (2012): 238, https://www.researchgate.net/publication/267706671_QALY_Kaliteye_Ayarli_Yasam_Yillari_QALY_Quality_Adjusted_Life_Year.
[5]
Zehra Edisan ve Funda Gülay Kadıoğlu, "Sağlıkla ilgili yaşam kalitesi ölçekleri: Etik açıdan bir değerlendirme," Türkiye Klinikleri Journal of Medical Ethics-Law and History 19, no. 1 (2011): 11, https://www.turkiyeklinikleri.com/article/en-saglikla-lgili-yasam-kalitesi-olcekleri-etik-acidan-bir-degerlendirme-60049.html.
No Discussion Added Yet
Start discussion for "Quality-Adjusted Life Year (QALY)" article
Definition and Calculation
Historical Development and Theoretical Foundations
Applications and Methods
Cost-Utility Analysis and Resource Allocation
Measuring Quality of Life
Direct Measurement Techniques
Indirect Measurement Techniques
Alternative Approaches and Criticisms
Utilitarian Foundation
Equity and Discrimination Concerns
Narrow Scope of Value Judgments
Alternative and Enhanced Models